…বাংলা
Barlekha Today logo
All the big stories — in your language, updated every 15 minutes
Home › Health › News
Health

Common blood pressure drug spironolactone helps more stroke survivors reach target in REDUCE trial

Staff Reporter
Common blood pressure drug spironolactone helps more stroke survivors reach target in REDUCE trial
Photo: Collected

A low-cost medication could help stroke survivors whose blood pressure remains elevated despite treatment, a new study suggests. The research, known as the REDUCE trial, looked at whether adding spironolactone, a medication commonly known as a water pill, could help lower blood pressure after a stroke.

The findings were presented at the American Heart Association's Scientific Sessions, held from 6 to 9 November 2026 in Chicago.

Participants were split into two groups. One added spironolactone to their regular treatment, while the other continued with usual post-stroke care.

Researchers then tracked the participants' blood pressure at home over the following six months to determine whether adding the medication made a difference.

After three months, the top blood pressure number was nearly eight points lower on average among people taking spironolactone compared with those receiving usual care — about 126 versus 133, the study said.

More patients taking spironolactone also reached the recommended blood pressure goal of less than 130/80 — 52 percent of those taking the medication compared with 30 percent receiving usual care.

Study co-lead author Dr Jordana Cohen, an associate professor of medicine and epidemiology at the University of Pennsylvania, said in a news release that lowering blood pressure is the most important step in preventing another stroke, yet many survivors struggle to reach recommended targets after a stroke.

She added that when spironolactone was added to post-stroke care, researchers saw a meaningful drop in blood pressure that may lower the risk of future strokes and heart attacks.

Dr Alfred Joshua, a California-based board-certified emergency physician and former chief medical officer who was not involved in the research, told Fox News Digital the findings are encouraging but do not yet show the medication prevents a subsequent stroke, noting the study measured blood pressure, so whether it leads to fewer repeat strokes remains an open question.

According to the US National Library of Medicine, spironolactone works by helping the body get rid of extra salt and water, which can lower blood pressure. It also causes the body to hold onto potassium, so patients taking it need their levels checked, its prescribing information states.

Joshua warned that high potassium is one of the main safety concerns because it can develop without symptoms, with higher risk for people with kidney problems and those taking certain medications or potassium supplements. The medication can also lower blood pressure enough to cause dizziness, he added.

He advised people whose blood pressure is still high after a stroke to bring their home readings to their clinician and ask whether the medication is a good fit.

The researchers noted limitations: the trial ended early with 160 participants instead of the planned 200, about 15 percent did not have blood pressure readings available at the three-month mark, and people taking spironolactone were also taking slightly more blood pressure medications overall than those receiving usual care.

The study was not designed to determine whether spironolactone actually prevents another stroke or heart attack, and larger and longer studies are needed to answer that question, according to the researchers.

Get the news firstNew stories in your inbox — subscribe free.

More in Health